TREMIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tremin, and what generic alternatives are available?
Tremin is a drug marketed by Schering and is included in one NDA.
The generic ingredient in TREMIN is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tremin
A generic version of TREMIN was approved as trihexyphenidyl hydrochloride by WATSON LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TREMIN?
- What are the global sales for TREMIN?
- What is Average Wholesale Price for TREMIN?
Summary for TREMIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Patent Applications: | 1,912 |
| DailyMed Link: | TREMIN at DailyMed |
US Patents and Regulatory Information for TREMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | TREMIN | trihexyphenidyl hydrochloride | TABLET;ORAL | 080381-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | TREMIN | trihexyphenidyl hydrochloride | TABLET;ORAL | 080381-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
